Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
European Journal of Heart Failure|September 10, 2023
Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: The LIFE-HF modelPascal M Burger, Gianluigi Savarese, Jasper Tromp, et al.
European Journal of Preventive Cardiology|February 9, 2026
Improving 10-year cardiovascular risk prediction in patients with established cardiovascular disease: flexible addition of risk predictors on top of the SMART2 risk scoreJoris Holtrop, Mari N Gynnild, Matthew Richards, et al.
European Heart Journal|February 15, 2022
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithmSteven H J Hageman, Ailsa J McKay, Peter Ueda, et al.
European Journal of Preventive Cardiology|May 19, 2021
Residual cardiovascular risk reduction guided by lifetime benefit estimation in patients with symptomatic atherosclerotic disease: effectiveness and cost-effectivenessSteven H J Hageman, Jannick A N Dorresteijn, Michiel L Bots, et al.
European Heart Journal|March 11, 2026
Risk prediction in patients with heart failure with preserved ejection fraction: the LIFE-Preserved modelTessa H Reitsma, Gianluigi Savarese, Łukasz Kuźma, et al.
European Heart Journal|March 11, 2026
Prediction of incident heart failure in established atherosclerotic cardiovascular disease: the SMART2-HF modelTessa H Reitsma, Carl-Emil Lim, Mari N Gynnild, et al.
BMJ Open|February 22, 2023
Cohort profile: the Utrecht Cardiovascular Cohort-Second Manifestations of Arterial Disease (UCC-SMART) Study-an ongoing prospective cohort study of patients at high cardiovascular risk in the NetherlandsMaria C Castelijns, Marga A G Helmink, Steven H J Hageman, et al.
European Heart Journal|June 5, 2026
Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 modelJoris Holtrop, Mari N Gynnild, Salil V Deo, et al.
European Journal of Preventive Cardiology|August 16, 2022
Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OPKunihiro Matsushita, Stephen Kaptoge, Steven H J Hageman, et al.
European Journal of Preventive Cardiology|May 16, 2024
Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regionsSteven H J Hageman, Stephen Kaptoge, Tamar I de Vries, et al.
Pageof 7